{"transactions":[{"id":916131,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":10266152,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Lux Total Opportunities, L.P. (\"LTO\"). Lux Total Opportunities Partners, LLC (\"LTOP\") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1376566},"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916130,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1450614,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Lux Total Opportunities, L.P. (\"LTO\"). Lux Total Opportunities Partners, LLC (\"LTOP\") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":194510},"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916129,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":303360,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Lux Total Opportunities, L.P. (\"LTO\"). Lux Total Opportunities Partners, LLC (\"LTOP\") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":40677},"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916128,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":3526215,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Lux Total Opportunities, L.P. (\"LTO\"). Lux Total Opportunities Partners, LLC (\"LTOP\") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":472822},"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916127,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":5289322,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Lux Co-Invest Opportunities II, L.P. (\"LCIO II\"). Lux Co-Invest Partners II, LLC (\"LCIP II\") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and the Reporting Person (the \"Individual Lux Managers\"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":709234},"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916126,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":530920,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Lux Total Opportunities, L.P. (\"LTO\"). Lux Total Opportunities Partners, LLC (\"LTOP\") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":71190},"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916125,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":796380,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Lux Co-Invest Opportunities II, L.P. (\"LCIO II\"). Lux Co-Invest Partners II, LLC (\"LCIP II\") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and the Reporting Person (the \"Individual Lux Managers\"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":106785},"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916124,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":2502252,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Lux Co-Invest Opportunities II, L.P. (\"LCIO II\"). Lux Co-Invest Partners II, LLC (\"LCIP II\") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and the Reporting Person (the \"Individual Lux Managers\"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":335521},"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916123,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":7807026,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held by Lux Ventures V, L.P. (\"LVV\"). Lux Venture Partners V, LLC (\"LVPV\") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1046827},"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916122,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":10000000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held by Lux Ventures V, L.P. (\"LVV\"). Lux Venture Partners V, LLC (\"LVPV\") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1340878},"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916121,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":2155765,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Lux Total Opportunities, L.P. (\"LTO\"). Lux Total Opportunities Partners, LLC (\"LTOP\") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":2294653,"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916120,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1151540,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Lux Co-Invest Opportunities II, L.P. (\"LCIO II\"). Lux Co-Invest Partners II, LLC (\"LCIP II\") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and the Reporting Person (the \"Individual Lux Managers\"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":1290428,"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916119,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":2387705,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held by Lux Ventures V, L.P. (\"LVV\"). Lux Venture Partners V, LLC (\"LVPV\") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":2387705,"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916118,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":138888,"price":18,"value":2499984.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Lux Total Opportunities, L.P. (\"LTO\"). Lux Total Opportunities Partners, LLC (\"LTOP\") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":138888,"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916117,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T23:27:59.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":138888,"price":18,"value":2499984.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Lux Co-Invest Opportunities II, L.P. (\"LCIO II\"). Lux Co-Invest Partners II, LLC (\"LCIP II\") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and the Reporting Person (the \"Individual Lux Managers\"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":138888,"source":{"system":"sec-edgar","filing":"0001193125-26-041549","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526041549/ownership.xml","form_type":"4"}},{"id":916858,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":10266152,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Lux Total Opportunities, L.P. (\"LTO\"). Lux Total Opportunities Partners, LLC (\"LTOP\") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1376566},"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":916857,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":1450614,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Lux Total Opportunities, L.P. (\"LTO\"). Lux Total Opportunities Partners, LLC (\"LTOP\") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":194510},"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":916856,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":303360,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Lux Total Opportunities, L.P. (\"LTO\"). Lux Total Opportunities Partners, LLC (\"LTOP\") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":40677},"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":916855,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":3526215,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Lux Total Opportunities, L.P. (\"LTO\"). Lux Total Opportunities Partners, LLC (\"LTOP\") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":472822},"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":916854,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":5289322,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Lux Co-Invest Opportunities II, L.P. (\"LCIO II\"). Lux Co-Invest Partners II, LLC (\"LCIP II\") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the \"Individual Lux Managers\"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":709234},"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":916853,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":530920,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Lux Total Opportunities, L.P. (\"LTO\"). Lux Total Opportunities Partners, LLC (\"LTOP\") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":71190},"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":916852,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":796380,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Lux Co-Invest Opportunities II, L.P. (\"LCIO II\"). Lux Co-Invest Partners II, LLC (\"LCIP II\") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the \"Individual Lux Managers\"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":106785},"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":916851,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":2502252,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Lux Co-Invest Opportunities II, L.P. (\"LCIO II\"). Lux Co-Invest Partners II, LLC (\"LCIP II\") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the \"Individual Lux Managers\"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":335521},"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":916850,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":7807026,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held by Lux Ventures V, L.P. (\"LVV\"). Lux Venture Partners V, LLC (\"LVPV\") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1046827},"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":916849,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":false,"shares":10000000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") on a 1-for-7.4578 basis and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held by Lux Ventures V, L.P. (\"LVV\"). Lux Venture Partners V, LLC (\"LVPV\") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1340878},"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":916848,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":2155765,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The Series C-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Lux Total Opportunities, L.P. (\"LTO\"). Lux Total Opportunities Partners, LLC (\"LTOP\") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":2294653,"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":916847,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":1151540,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series B Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Series B-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Lux Co-Invest Opportunities II, L.P. (\"LCIO II\"). Lux Co-Invest Partners II, LLC (\"LCIP II\") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the \"Individual Lux Managers\"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":1290428,"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":916846,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-06","kind":"exercise","planned":false,"acquired":true,"shares":2387705,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series A Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (\"IPO\") on a 1-for-7.4578 basis and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series A-1 Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's IPO on a 1-for-7.4578 basis and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares are held by Lux Ventures V, L.P. (\"LVV\"). Lux Venture Partners V, LLC (\"LVPV\") is the general partner of LVV and exercises voting and dispositive power over the shares noted herein held by LVV. The Individual Lux Managers are the individual managing members of LVPV. The Individual Lux Managers, as the sole managers of LVPV, may be deemed to beneficially own the shares held by LVV. Each of LVPV and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":2387705,"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":916845,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":138888,"price":18,"value":2499984.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Lux Total Opportunities, L.P. (\"LTO\"). Lux Total Opportunities Partners, LLC (\"LTOP\") is the general partner of LTO and exercises voting and dispositive power over the shares noted herein held by LTO. The Individual Lux Managers are the individual managing members of LTOP. The Individual Lux Managers, as the sole managers of LTOP, may be deemed to beneficially own the shares held by LTO. Each of LTOP and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of their pecuniary interest therein."}],"balance_after":138888,"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":916844,"issuer":{"id":5380,"kind":"organization","name":"Eikon Therapeutics, Inc.","symbol":"EIKN"},"owners":[{"id":67486,"kind":"organization","name":"Lux Venture Partners V, LLC","position":1,"cik":"0001698118","reported_name":"Lux Venture Partners V, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":3,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67488,"kind":"organization","name":"Lux Ventures V, L.P.","position":4,"cik":"0001698008","reported_name":"Lux Ventures V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67489,"kind":"organization","name":"Lux Co-Invest Opportunities II, L.P.","position":5,"cik":"0001783916","reported_name":"Lux Co-Invest Opportunities II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67490,"kind":"organization","name":"Lux Total Opportunities, L.P.","position":6,"cik":"0001864658","reported_name":"Lux Total Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T18:25:01.000Z","date":"2026-02-04","kind":"purchase","planned":false,"acquired":true,"shares":138888,"price":18,"value":2499984.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Lux Co-Invest Opportunities II, L.P. (\"LCIO II\"). Lux Co-Invest Partners II, LLC (\"LCIP II\") is the general partner of LCIO II and exercises voting and dispositive power over the shares noted herein held by LCIO II. Peter Hebert and Josh Wolfe, a member of the Issuer's board of directors (the \"Individual Lux Managers\"), are the individual managing members of LCIP II. The Individual Lux Managers, and as the sole managers of LCIP II, may be deemed to beneficially own the shares held by LCIO II. Each of LCIP II and the Individual Lux Managers disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein."}],"balance_after":138888,"source":{"system":"sec-edgar","filing":"0001193125-26-041544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783916/000119312526041544/ownership.xml","form_type":"4"}},{"id":1848548,"issuer":{"id":90701,"kind":"organization","name":"Shapeways Holdings, Inc.","symbol":"SHPW"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-20T16:13:32.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the one-year anniversary of June 15, 2023, subject to the Reporting Person's continuous service with the issuer through such date."}],"balance_after":62500,"derivative":{"exercise_price":0.4254,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001628280-23-022696","document":"wk-form4_1687291998.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1784851/000162828023022696/wk-form4_1687291998.xml","form_type":"4"}},{"id":2190926,"issuer":{"id":4949,"kind":"organization","name":"Aeva Technologies, Inc.","symbol":"AEVA"},"owners":[{"id":67487,"kind":"person","name":"Hebert Peter","position":1,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":3,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":4,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":5,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":6,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-09T17:01:48.000Z","date":"2022-08-05","kind":"other","acquired":false,"shares":7346159,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":14692316,"source":{"system":"sec-edgar","filing":"0001493152-22-021786","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000149315222021786/ownership.xml","form_type":"4"}},{"id":2235258,"issuer":{"id":90701,"kind":"organization","name":"Shapeways Holdings, Inc.","symbol":"SHPW"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T08:27:42.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"), which represent a contingent right to receive one share of Common Stock for each RSU.  The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the one-year anniversary of June 8, 2022, subject to the Reporting Person's continuous service with the issuer through such date."}],"balance_after":31250,"source":{"system":"sec-edgar","filing":"0001628280-22-016759","document":"wf-form4_165486404803400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1784851/000162828022016759/wf-form4_165486404803400.xml","form_type":"4"}},{"id":2302698,"issuer":{"id":15235,"kind":"organization","name":"Science 37 Holdings, Inc.","symbol":"SNCE"},"owners":[{"id":128249,"kind":"organization","name":"Lux Capital Management, LLC","position":1,"cik":"0001592843","reported_name":"Lux Capital Management, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":2,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":3,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":4,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":5,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":6,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":7,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-04-06T20:43:20.000Z","date":"2022-04-04","kind":"other","acquired":false,"shares":2914667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Lux Ventures IV, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution of 2,914,667 shares from Lux Ventures IV, L.P. to its partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares held by Lux Ventures IV, L.P. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares held by Lux Co-Invest Opportunities, L.P. Peter Hebert and Joshua Wolfe are the individual managers of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC and may be deemed to share voting and dispositive power over the shares held by each of Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P., Lux Capital Management, LLC, as the investment manager for each of Lux Venture Partners IV, LLC and Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power over the shares held by each of Lux Ventures IV, L.P. and Lux Co-Invest Opportunities, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of Lux Capital Management, LLC, Lux Venture Partners IV, LLC, Lux Co-Invest Partners, LLC, Peter Hebert and Joshua Wolfe disclaim beneficial ownership over the shares reported herein except to the extent of their pecuniary interest therein, if any."}],"balance_after":8743999,"source":{"system":"sec-edgar","filing":"0000905718-22-000545","document":"science_fm4apr42022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819113/000090571822000545/science_fm4apr42022.xml","form_type":"4"}},{"id":2428769,"issuer":{"id":82549,"kind":"organization","name":"Matterport, Inc./DE","symbol":"MTTR"},"owners":[{"id":67487,"kind":"person","name":"Hebert Peter","position":1,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131175,"kind":"organization","name":"Lux Ventures III, L.P.","position":3,"cik":"0001534238","reported_name":"Lux Ventures III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131176,"kind":"organization","name":"Lux Ventures III Special Founders Fund, L.P.","position":4,"cik":"0001534241","reported_name":"Lux Ventures III Special Founders Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":131177,"kind":"organization","name":"Lux Ventures Cayman III, L.P.","position":5,"cik":"0001569760","reported_name":"Lux Ventures Cayman III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":6,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-01-21T07:16:54.000Z","date":"2022-01-18","kind":"other","acquired":false,"shares":6306411,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution of (i) 4,406,063 shares from Lux Ventures III, L.P. to its partners, (ii) 2,168 shares from Lux Ventures Special Founders Fund, L.P. to its partners, (iii) 209,042 shares from Lux Ventures Cayman III, L.P. to its partners, and (iv) 1,689,138 shares from Lux Co-Invest Opportunities, L.P. to its partners. Lux Venture Partners III, LLC is the general partner of each of Lux Ventures III L.P. and Lux Ventures III Special Founders Fund, L.P. and exercises voting and dispositive power over the shares held thereby. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Ventures Cayman III General Partner Limited is the general partner of Lux Ventures Cayman III, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures Cayman III, L.P."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from footnote 1) Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited. The individual managers, as the sole managers of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures III, L.P., Lux Co-Invest Opportunities, L.P., Lux Ventures Cayman III, L.P. and Lux Ventures III Special Founders Fund, L.P. Each of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, and the individual managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Pro rata distribution of (i) 4,406,063 shares from Lux Ventures III, L.P. to its partners, (ii) 2,168 shares from Lux Ventures Special Founders Fund, L.P. to its partners, (iii) 209,042 shares from Lux Ventures Cayman III, L.P. to its partners, and (iv) 1,689,138 shares from Lux Co-Invest Opportunities, L.P. to its partners. Lux Venture Partners III, LLC is the general partner of each of Lux Ventures III L.P. and Lux Ventures III Special Founders Fund, L.P. and exercises voting and dispositive power over the shares held thereby. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Ventures Cayman III General Partner Limited is the general partner of Lux Ventures Cayman III, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures Cayman III, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"(continued from footnote 1) Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited. The individual managers, as the sole managers of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures III, L.P., Lux Co-Invest Opportunities, L.P., Lux Ventures Cayman III, L.P. and Lux Ventures III Special Founders Fund, L.P. Each of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, and the individual managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":18919230,"source":{"system":"sec-edgar","filing":"0000905718-22-000125","document":"matterport_fm4jan182022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683771/000090571822000125/matterport_fm4jan182022.xml","form_type":"4"}},{"id":2478983,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":1,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":2,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":3,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":4,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":67487,"kind":"person","name":"Hebert Peter","position":5,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":6,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Class A common stock","published_at":"2021-12-09T20:57:21.000Z","date":"2021-12-07","kind":"other","acquired":false,"shares":4265576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":13021519,"source":{"system":"sec-edgar","filing":"0000905718-21-001582","document":"recursion_fm4dec72021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000090571821001582/recursion_fm4dec72021.xml","form_type":"4"}},{"id":2549090,"issuer":{"id":9606,"kind":"organization","name":"Latch, Inc.","symbol":"LTCH"},"owners":[{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":1,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":2,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":3,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":4,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":5,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":6,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T16:31:46.000Z","date":"2021-09-28","kind":"other","acquired":false,"shares":1358164,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pro rata distribution from Lux Co-Invest Opportunities, L.P. to its partners. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. The Individual Lux Managers are the individual managing members of Lux Co-Invest Partners, LLC. The Individual Lux Managers, as the sole managers of Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Co-Invest Opportunities, L.P. Each of Lux Co-Invest Partners, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Pro rata distribution from Lux Co-Invest Opportunities, L.P. to its partners. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. The Individual Lux Managers are the individual managing members of Lux Co-Invest Partners, LLC. The Individual Lux Managers, as the sole managers of Lux Co-Invest Partners, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Co-Invest Opportunities, L.P. Each of Lux Co-Invest Partners, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest."}],"balance_after":4084493,"source":{"system":"sec-edgar","filing":"0000905718-21-001276","document":"latch_fm4sep282021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000090571821001276/latch_fm4sep282021.xml","form_type":"4"}},{"id":2549089,"issuer":{"id":9606,"kind":"organization","name":"Latch, Inc.","symbol":"LTCH"},"owners":[{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":1,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":2,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":3,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":4,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":5,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":6,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T16:31:46.000Z","date":"2021-09-28","kind":"other","acquired":false,"shares":2409489,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":7228469,"source":{"system":"sec-edgar","filing":"0000905718-21-001276","document":"latch_fm4sep282021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000090571821001276/latch_fm4sep282021.xml","form_type":"4"}},{"id":2553806,"issuer":{"id":90701,"kind":"organization","name":"Shapeways Holdings, Inc.","symbol":"SHPW"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T21:48:32.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":300000,"price":10,"value":3000000.0,"ownership":{"direct":false,"nature":"Held by Lux Co-Invest Opportunities, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners III, LLC is the general partner of Lux Ventures III, LP and of Lux Ventures III Special Founders Fund, L.P. Lux Ventures Cayman III General Partner Limited is the general partner of Lux Ventures Cayman III, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures Cayman III, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited. The individual"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"managers, as the sole managers of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures III, L.P., Lux Co-Invest Opportunities, L.P., Lux Ventures Cayman III, L.P. and Lux Ventures III Special Founders Fund, L.P. Each of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, and the individual managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001104659-21-122225","document":"tm2129009-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1784851/000110465921122225/tm2129009-11_4seq1.xml","form_type":"4"}},{"id":2553805,"issuer":{"id":90701,"kind":"organization","name":"Shapeways Holdings, Inc.","symbol":"SHPW"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T21:48:32.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":181,"ownership":{"direct":false,"nature":"Held by Lux Ventures III Special Founders Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the Merger, the Reporting Person received (i) 1,633 shares of Common Stock in the Issuer and (ii) 181 Earn-out Shares. The Earn-out Shares will no longer be subject forfeiture upon the satisfaction of the Earn-out Conditions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners III, LLC is the general partner of Lux Ventures III, LP and of Lux Ventures III Special Founders Fund, L.P. Lux Ventures Cayman III General Partner Limited is the general partner of Lux Ventures Cayman III, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures Cayman III, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited. The individual"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"managers, as the sole managers of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures III, L.P., Lux Co-Invest Opportunities, L.P., Lux Ventures Cayman III, L.P. and Lux Ventures III Special Founders Fund, L.P. Each of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, and the individual managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":181,"source":{"system":"sec-edgar","filing":"0001104659-21-122225","document":"tm2129009-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1784851/000110465921122225/tm2129009-11_4seq1.xml","form_type":"4"}},{"id":2553804,"issuer":{"id":90701,"kind":"organization","name":"Shapeways Holdings, Inc.","symbol":"SHPW"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T21:48:32.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":1633,"ownership":{"direct":false,"nature":"Held by Lux Ventures III Special Founders Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the Merger, the Reporting Person received (i) 1,633 shares of Common Stock in the Issuer and (ii) 181 Earn-out Shares. The Earn-out Shares will no longer be subject forfeiture upon the satisfaction of the Earn-out Conditions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners III, LLC is the general partner of Lux Ventures III, LP and of Lux Ventures III Special Founders Fund, L.P. Lux Ventures Cayman III General Partner Limited is the general partner of Lux Ventures Cayman III, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures Cayman III, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited. The individual"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"managers, as the sole managers of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures III, L.P., Lux Co-Invest Opportunities, L.P., Lux Ventures Cayman III, L.P. and Lux Ventures III Special Founders Fund, L.P. Each of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, and the individual managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":1633,"source":{"system":"sec-edgar","filing":"0001104659-21-122225","document":"tm2129009-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1784851/000110465921122225/tm2129009-11_4seq1.xml","form_type":"4"}},{"id":2553803,"issuer":{"id":90701,"kind":"organization","name":"Shapeways Holdings, Inc.","symbol":"SHPW"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T21:48:32.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":17267,"ownership":{"direct":false,"nature":"Held by Lux Ventures Cayman III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In connection with the Merger, the Reporting Person received (i) 155,400 shares of Common Stock in the Issuer and (ii) 17,267 Earn-out Shares. The Earn-out Shares will no longer be subject forfeiture upon the satisfaction of the Earn-out Conditions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners III, LLC is the general partner of Lux Ventures III, LP and of Lux Ventures III Special Founders Fund, L.P. Lux Ventures Cayman III General Partner Limited is the general partner of Lux Ventures Cayman III, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures Cayman III, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited. The individual"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"managers, as the sole managers of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures III, L.P., Lux Co-Invest Opportunities, L.P., Lux Ventures Cayman III, L.P. and Lux Ventures III Special Founders Fund, L.P. Each of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, and the individual managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":17267,"source":{"system":"sec-edgar","filing":"0001104659-21-122225","document":"tm2129009-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1784851/000110465921122225/tm2129009-11_4seq1.xml","form_type":"4"}},{"id":2553802,"issuer":{"id":90701,"kind":"organization","name":"Shapeways Holdings, Inc.","symbol":"SHPW"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T21:48:32.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":155400,"ownership":{"direct":false,"nature":"Held by Lux Ventures Cayman III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In connection with the Merger, the Reporting Person received (i) 155,400 shares of Common Stock in the Issuer and (ii) 17,267 Earn-out Shares. The Earn-out Shares will no longer be subject forfeiture upon the satisfaction of the Earn-out Conditions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners III, LLC is the general partner of Lux Ventures III, LP and of Lux Ventures III Special Founders Fund, L.P. Lux Ventures Cayman III General Partner Limited is the general partner of Lux Ventures Cayman III, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures Cayman III, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited. The individual"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"managers, as the sole managers of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures III, L.P., Lux Co-Invest Opportunities, L.P., Lux Ventures Cayman III, L.P. and Lux Ventures III Special Founders Fund, L.P. Each of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, and the individual managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":155400,"source":{"system":"sec-edgar","filing":"0001104659-21-122225","document":"tm2129009-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1784851/000110465921122225/tm2129009-11_4seq1.xml","form_type":"4"}},{"id":2553801,"issuer":{"id":90701,"kind":"organization","name":"Shapeways Holdings, Inc.","symbol":"SHPW"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T21:48:32.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":284846,"ownership":{"direct":false,"nature":"Held by Lux Co-Invest Opportunities, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Merger, the Reporting Person received (i) 2,563,614 shares of Common Stock in the Issuer and (ii) 284,846 Earn-out Shares. The Earn-out Shares will no longer be subject forfeiture upon the satisfaction of the Earn-out Conditions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners III, LLC is the general partner of Lux Ventures III, LP and of Lux Ventures III Special Founders Fund, L.P. Lux Ventures Cayman III General Partner Limited is the general partner of Lux Ventures Cayman III, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures Cayman III, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited. The individual"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"managers, as the sole managers of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures III, L.P., Lux Co-Invest Opportunities, L.P., Lux Ventures Cayman III, L.P. and Lux Ventures III Special Founders Fund, L.P. Each of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, and the individual managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":284846,"source":{"system":"sec-edgar","filing":"0001104659-21-122225","document":"tm2129009-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1784851/000110465921122225/tm2129009-11_4seq1.xml","form_type":"4"}},{"id":2553800,"issuer":{"id":90701,"kind":"organization","name":"Shapeways Holdings, Inc.","symbol":"SHPW"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T21:48:32.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":2563614,"ownership":{"direct":false,"nature":"Held by Lux Co-Invest Opportunities, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Merger, the Reporting Person received (i) 2,563,614 shares of Common Stock in the Issuer and (ii) 284,846 Earn-out Shares. The Earn-out Shares will no longer be subject forfeiture upon the satisfaction of the Earn-out Conditions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners III, LLC is the general partner of Lux Ventures III, LP and of Lux Ventures III Special Founders Fund, L.P. Lux Ventures Cayman III General Partner Limited is the general partner of Lux Ventures Cayman III, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures Cayman III, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited. The individual"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"managers, as the sole managers of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures III, L.P., Lux Co-Invest Opportunities, L.P., Lux Ventures Cayman III, L.P. and Lux Ventures III Special Founders Fund, L.P. Each of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, and the individual managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":2563614,"source":{"system":"sec-edgar","filing":"0001104659-21-122225","document":"tm2129009-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1784851/000110465921122225/tm2129009-11_4seq1.xml","form_type":"4"}},{"id":2553799,"issuer":{"id":90701,"kind":"organization","name":"Shapeways Holdings, Inc.","symbol":"SHPW"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T21:48:32.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":381111,"ownership":{"direct":false,"nature":"Held by Lux Ventures III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger described in that certain Agreement and Plan of Merger and Reorganization, dated as of April 28, 2021 (the \"Merger Agreement\"), by and among Galileo Acquisition Corp., now known as Shapeways Holdings, Inc. (the \"Issuer\"), Galileo Acquisition Holdings, Inc. (\"Merger Sub\"), and Shapeways, Inc. (\"Shapeways\"), pursuant to which Merger Sub merged with and into Shapeways, with Shapeways surviving as a wholly-owned subsidiary of the Issuer. In connection with the Merger, the Reporting Person received (i) 3,430,000 shares of Common Stock in the Issuer and (ii) 381,111 restricted Common Stock of the Issuer (the \"Earn-out Shares\"). The Earn-out Shares will no longer be subject forfeiture upon the satisfaction"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"of certain share price vesting conditions (the \"Earn-out Conditions\") as follows: (i) if, at any time prior to September 29, 2024 (the \"Earn-out Period\") the VWAP (as defined in the Merger Agreement) of the Issuer's Common Stock equals or exceeds $14.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations and similar transactions after the Transaction Date) for 30 consecutive trading days occurring during the period beginning on the Transaction Date and ending on the Expiration Date, one half (1/2) of the Earn-out Shares shall vest; and (ii) if, at any time prior to the Earn-out Period, the VWAP (as defined in the Merger Agreement) of the Issuer's Common Stock equals or exceeds $16.00 per share (as adjusted"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"for stock splits, stock dividends, reorganizations and recapitalizations and similar transactions after the Transaction Date) for 30 consecutive trading days occurring during the period beginning on the Transaction Date and ending on the Expiration Date, one half (1/2) of the Earn-out Shares shall vest. If the Performance Milestones are not met during the Earn-out Period, then the applicable Earn-out Shares shall be automatically forfeited. If the Earn-out Conditions are not met during the Earn-out Period, then the applicable Earn-out Shares shall be automatically forfeited. On the effective date of the Merger, the closing price of the Issuer's Common Stock was $8.54 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners III, LLC is the general partner of Lux Ventures III, LP and of Lux Ventures III Special Founders Fund, L.P. Lux Ventures Cayman III General Partner Limited is the general partner of Lux Ventures Cayman III, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures Cayman III, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited. The individual"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"managers, as the sole managers of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures III, L.P., Lux Co-Invest Opportunities, L.P., Lux Ventures Cayman III, L.P. and Lux Ventures III Special Founders Fund, L.P. Each of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, and the individual managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":381111,"source":{"system":"sec-edgar","filing":"0001104659-21-122225","document":"tm2129009-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1784851/000110465921122225/tm2129009-11_4seq1.xml","form_type":"4"}},{"id":2553798,"issuer":{"id":90701,"kind":"organization","name":"Shapeways Holdings, Inc.","symbol":"SHPW"},"owners":[{"id":67419,"kind":"person","name":"Wolfe Josh","position":1,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-01T21:48:32.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":3430000,"ownership":{"direct":false,"nature":"Held by Lux Ventures III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the merger described in that certain Agreement and Plan of Merger and Reorganization, dated as of April 28, 2021 (the \"Merger Agreement\"), by and among Galileo Acquisition Corp., now known as Shapeways Holdings, Inc. (the \"Issuer\"), Galileo Acquisition Holdings, Inc. (\"Merger Sub\"), and Shapeways, Inc. (\"Shapeways\"), pursuant to which Merger Sub merged with and into Shapeways, with Shapeways surviving as a wholly-owned subsidiary of the Issuer. In connection with the Merger, the Reporting Person received (i) 3,430,000 shares of Common Stock in the Issuer and (ii) 381,111 restricted Common Stock of the Issuer (the \"Earn-out Shares\"). The Earn-out Shares will no longer be subject forfeiture upon the satisfaction"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"of certain share price vesting conditions (the \"Earn-out Conditions\") as follows: (i) if, at any time prior to September 29, 2024 (the \"Earn-out Period\") the VWAP (as defined in the Merger Agreement) of the Issuer's Common Stock equals or exceeds $14.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations and similar transactions after the Transaction Date) for 30 consecutive trading days occurring during the period beginning on the Transaction Date and ending on the Expiration Date, one half (1/2) of the Earn-out Shares shall vest; and (ii) if, at any time prior to the Earn-out Period, the VWAP (as defined in the Merger Agreement) of the Issuer's Common Stock equals or exceeds $16.00 per share (as adjusted"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"for stock splits, stock dividends, reorganizations and recapitalizations and similar transactions after the Transaction Date) for 30 consecutive trading days occurring during the period beginning on the Transaction Date and ending on the Expiration Date, one half (1/2) of the Earn-out Shares shall vest. If the Performance Milestones are not met during the Earn-out Period, then the applicable Earn-out Shares shall be automatically forfeited. If the Earn-out Conditions are not met during the Earn-out Period, then the applicable Earn-out Shares shall be automatically forfeited. On the effective date of the Merger, the closing price of the Issuer's Common Stock was $8.54 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners III, LLC is the general partner of Lux Ventures III, LP and of Lux Ventures III Special Founders Fund, L.P. Lux Ventures Cayman III General Partner Limited is the general partner of Lux Ventures Cayman III, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures Cayman III, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited. The individual"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"managers, as the sole managers of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures III, L.P., Lux Co-Invest Opportunities, L.P., Lux Ventures Cayman III, L.P. and Lux Ventures III Special Founders Fund, L.P. Each of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, and the individual managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":3430000,"source":{"system":"sec-edgar","filing":"0001104659-21-122225","document":"tm2129009-11_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1784851/000110465921122225/tm2129009-11_4seq1.xml","form_type":"4"}},{"id":2573300,"issuer":{"id":4949,"kind":"organization","name":"Aeva Technologies, Inc.","symbol":"AEVA"},"owners":[{"id":67487,"kind":"person","name":"Hebert Peter","position":1,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":2,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124765,"kind":"organization","name":"Lux Ventures IV, L.P.","position":3,"cik":"0001633331","reported_name":"Lux Ventures IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124766,"kind":"organization","name":"Lux Co-Invest Opportunities, L.P.","position":4,"cik":"0001722022","reported_name":"Lux Co-Invest Opportunities, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124767,"kind":"organization","name":"Lux Venture Partners IV, LLC","position":5,"cik":"0001633332","reported_name":"Lux Venture Partners IV, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124768,"kind":"organization","name":"Lux Co-Invest Partners, LLC","position":6,"cik":"0001722021","reported_name":"Lux Co-Invest Partners, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-09-10T16:56:50.000Z","date":"2021-09-08","kind":"other","acquired":false,"shares":7346159,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the \"Individual Lux Managers\"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein."}],"balance_after":22038475,"source":{"system":"sec-edgar","filing":"0000905718-21-001184","document":"aevatech_fm4sep82021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1722021/000090571821001184/aevatech_fm4sep82021.xml","form_type":"4"}},{"id":2996544,"issuer":{"id":145615,"kind":"organization","name":"Lux Health Tech Acquisition Corp.","symbol":"LUXA"},"owners":[{"id":145616,"kind":"organization","name":"Lux Encore Sponsor, LP","position":1,"cik":"0001829620","reported_name":"Lux Encore Sponsor, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":145617,"kind":"organization","name":"Lux Encore Holdings, LLC","position":2,"cik":"0001829994","reported_name":"Lux Encore Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67419,"kind":"person","name":"Wolfe Josh","position":3,"cik":"0001830001","reported_name":"Wolfe Josh","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67487,"kind":"person","name":"Hebert Peter","position":4,"cik":"0001683771","reported_name":"Hebert Peter","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2020-11-02T17:02:05.000Z","date":"2020-10-29","kind":"purchase","acquired":true,"shares":5933333,"price":1.5,"value":8899999.5,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The warrants will become exercisable commencing on the later of 12 months from the closing of the Issuer's initial public offering or 30 days after the completion of the Issuer's initial business combination, and will expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The warrants will become exercisable commencing on the later of 12 months from the closing of the Issuer's initial public offering or 30 days after the completion of the Issuer's initial business combination, and will expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Lux Encore Sponsor, LP  (\"Sponsor\") is the record holder of the warrants reported herein. Lux Encore Holdings, LLC (\"Lux GP\") is the general partner of Sponsor. Josh Wolfe and Peter Hebert are the managing members of Lux GP. As such, Lux GP and each of Messers. Wolfe and Hebert may be deemed to share beneficial ownership of the warrants held directly by Sponsor. Lux GP and Messers. Wolfe and Hebert disclaim any beneficial ownership of such shares other than to the extent of their pecuniary interest therein, if any."}],"balance_after":5933333,"derivative":{"exercise_price":11.5,"underlying":"Class A Common Stock","underlying_shares":5933333},"source":{"system":"sec-edgar","filing":"0000899243-20-030098","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683771/000089924320030098/doc4.xml","form_type":"4"}}]}